Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment Due to AD”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Early research (Phase 1)Study completedNCT06114745
What this trial is testing

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Atridia Pty Ltd. 2
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Study completedNCT04191486
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Mild Cognitive Impairment
FUJIFILM Toyama Chemical Co., Ltd. 221
Large-scale testing (Phase 3)Looking for participantsNCT07169578
What this trial is testing

Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT05399888
What this trial is testing

Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease Dementia
Biogen 416
Not applicableLooking for participantsNCT07224607
What this trial is testing

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Who this might be right for
Alzheimer's Disease
Cedars-Sinai Medical Center 45
Not applicableLooking for participantsNCT07089303
What this trial is testing

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT06182085
What this trial is testing

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
PRInnovation GmbH 304
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Testing effectiveness (Phase 2)Study completedNCT04602624
What this trial is testing

Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Dementia
Supernus Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Ended earlyNCT04795466
What this trial is testing

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Novartis Pharmaceuticals 34
Load More Results